As a clinician-scientist, Dr. Ramilo’s main area of research focuses on respiratory syncytial virus — its pathogenesis, effects on young children and treatment options.
“Dr. Ramilo’s research explores the long-term impact of early RSV infections on the development of children’s immune systems and how they will respond to other infections as they grow,” according to St. Jude. “He is heavily involved in translational and clinical research aimed at understanding the host immune response to infections and vaccines using genomics and system analysis tools.”
Previously, Dr. Ramilo was the division chief of infectious diseases at Nationwide Children’s Hospital in Columbus, Ohio.
St. Jude said it started the process of recruiting Dr. Ramilo prior to this winter’s RSV surge in hospitals throughout the U.S., but hospital leaders said the outbreak underscores the need for more research into this disease.
Dr. Ramilo said he looks forward to continuing his research in the pediatric infectious disease field, including RSV’s long-term impact on children’s immune systems and how contracting the disease early might affect how children will respond to other infections in the future.
“He is heavily involved in translational and clinical research aimed at understanding the host immune response to infections and vaccines using genomics and system analysis tools,” the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
